서울대학교 중앙도서관
S-Space 소개
My S-Space
로그인이 필요합니다.
Login

S-Space

Publications

Detailed Information

Recalcitrant Atopic Dermatitis Treated with Omalizumab

DC Field Value Language
dc.contributor.authorPark, Se-Young-
dc.contributor.authorChoi, Mi-Ra-
dc.contributor.authorNa, Jung-Im-
dc.contributor.authorYoun, Sang-Woong-
dc.contributor.authorHuh, Chang-Hun-
dc.contributor.authorPark, Kyoung-Chan-
dc.date.accessioned2012-07-04T00:20:21Z-
dc.date.available2012-07-04T00:20:21Z-
dc.date.issued2010-08-
dc.identifier.citationANNALS OF DERMATOLOGY; Vol.22, no.3; 349-352ko_KR
dc.identifier.issn1013-9087-
dc.identifier.urihttps://hdl.handle.net/10371/78334-
dc.description.abstractAtopic dermatitis (AD) is a chronic cutaneous inflammatory disease. Various categories of therapeutic medications are used for treating AD. Omalizumab is a monoclonal anti-IgE antibody that binds to IgE molecules at the high-affinity receptor (Fc epsilon RI) binding site. Therefore, omalizumab can be used as a potential new systemic treatment agent for recalcitrant AD patients with elevated IgE levels. A 34-year-old man had been treated for AD with several topical and oral agents. However, he was refractory to these therapies and his serum IgE levels were very high. We treated him with omalizumab. After 8 months of the treatment, his symptoms were notably improved and the SCORAD index was decreased. Thus, we report on the first case of recalcitrant AD that was successfully treated with omalizumab in Korea.ko_KR
dc.language.isoenko_KR
dc.publisherKOREAN DERMATOLOGICAL ASSOCko_KR
dc.subjectAtopic dermatitisko_KR
dc.subjectBiologiesko_KR
dc.subjectOmalizumabko_KR
dc.titleRecalcitrant Atopic Dermatitis Treated with Omalizumabko_KR
dc.typeArticleko_KR
dc.contributor.AlternativeAuthor박세영-
dc.contributor.AlternativeAuthor최미라-
dc.contributor.AlternativeAuthor나정임-
dc.contributor.AlternativeAuthor윤상웅-
dc.contributor.AlternativeAuthor박경찬-
dc.contributor.AlternativeAuthor허창훈-
dc.identifier.doi10.5021/ad.2010.22.3.349-
dc.citation.journaltitleANNALS OF DERMATOLOGY-
dc.description.citedreferenceLowe PJ, 2009, BRIT J CLIN PHARMACO, V68, P61, DOI 10.1111/j.1365-2125.2009.03401.x-
dc.description.citedreferenceSALVIN RG, 2009, J ALLERGY CLIN IMMUN, V123, P107-
dc.description.citedreferenceBieber T, 2008, NEW ENGL J MED, V358, P1483-
dc.description.citedreferenceNowak D, 2006, RESP MED, V100, P1907, DOI 10.1016/j.rmed.2005.10.004-
dc.description.citedreferenceAkdis CA, 2006, J ALLERGY CLIN IMMUN, V118, P152, DOI 10.1016/j.jaci.2006.03.045-
dc.description.citedreferenceVigo PG, 2006, J AM ACAD DERMATOL, V55, P168, DOI 10.1016/j.jaad.2005.12.045-
dc.description.citedreferenceLane JE, 2006, J AM ACAD DERMATOL, V54, P68, DOI 10.1016/j.jaad.2005.09.030-
dc.description.citedreferenceKrathen RA, 2005, J AM ACAD DERMATOL, V53, P338, DOI 10.1016/j.jaad.2005.02.014-
dc.description.citedreferenceLEE BH, 2005, KOREAN J DERMATOL, V43, P1626-
dc.description.citedreferenceKUANPRASERT N, 2002, AUSTRALAS J DERMATOL, V43, P125-
dc.description.citedreferenceStingl G, 2001, J AM ACAD DERMATOL, V45, pS17-
dc.description.citedreferenceNeuber K, 2000, BRIT J DERMATOL, V143, P385-
dc.description.citedreferenceJolles S, 2000, BRIT J DERMATOL, V142, P551-
dc.description.tc4-
Appears in Collections:
Files in This Item:

Altmetrics

Item View & Download Count

Show Simple Item Record
Find it @ SNU

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share

qrcode
SNS Share